New Market Study: "Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2012"
Global Markets Direct's, 'Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia. Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release